Reported results
- Research and development expenses were $40.2 million for the third quarter of 2026, compared to $42.0 million for the third quarter of 2025.
- General and administrative expenses were $12.4 million for the third quarter of 2026, compared to $13.6 million for the third quarter of 2025.
- Net loss was $49.4 million for the third quarter of 2026, compared to $50.6 million for the third quarter of 2025.
- Basic and diluted net loss per share of common stock was $0.74 for the three months ended September 30, 2026, compared to $0.77 for the three months ended September 30, 2025.
- Cash, cash equivalents, short- and long-term investments, and interest receivable were $313.8 million as of September 30, 2026.
Guidance
- Cullinan expects its cash resources to provide runway into 2029 under its current operating plan.
Price and volatility reaction
The stock moved -4.3% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved +18.6 vol points across the event (constant-maturity series — not the front-week crush).
| Measure | Value | Basis |
|---|---|---|
| Close before release | 11.73 | 2026-11-09 |
| Close after release | 11.23 | 2026-11-10 |
| Realised move | -4.3% | close to close |
| 30d ATM IV change | +18.6 vol pts | constant-maturity series, not the front expiry |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-11-10 (8-K, Item 2.02). Read the original filing on sec.gov.
